Takeda nelle notizie
Trasformare vite attraverso la scienza
Tamtam ha trovato 20 articoli recenti su Takeda.
- Innovent stock gets USD 1.2 billion Takeda oncology deal
- Takeda Says Samsung Biosimilar Plans Infringe Entyvio IP
- International Plasma Awareness Week 2026: Takeda and Indonesia’s Health Ministry to raise plasma awareness
- Ghana’s Prof. Priscilla Kolibea Mante Leads KNUST Team to Secure $5.1 Million Takeda Global CSR Award
- Takeda’s zasocitinib raises bar for oral psoriasis drugs
- A Takeda spinout builds case for its Parkinson’s drug
- Takeda stock after-hours: prior close at EUR 15.55
- Should Phase 3 Psoriasis Win Require Action From Takeda Stock Investors?
- Takeda partners with Innovent: what USD 1.20 billion means for Innovent Biologics stock
- Takeda Pharmaceuticals' Psoriasis Pill Zasocitinib
- Corus International Receives $6.4 Million Grant From Takeda to Reduce Climate-Related Health Risks in Nepal
- Corus International receives $6.4 million grant from Takeda to reduce climate-related health risks in Nepal
- Takeda Pharmaceutical (TSE:4502) Could Be 13% Undervalued After Fresh Psoriasis Trial Data
- Takeda Pharmaceuticals (NYSE:TAK): The Only Japanese Pharma Now Enters The Three Years That Will Define Its Future
- Takeda (TSE:4502) Stock Looks Below Fair Value Even After A 120% Run
- Takeda Pharmaceutical (TSE:4502) Could Be 13% Undervalued On Strong Phase 3 Psoriasis Data
- Takeda Pharmaceutical: Reimagining R&D With AI
- Allana Sanborn Steps Into New Role at Takeda Oncology
- Takeda details Phase 3 psoriasis comparison with Sotyktu
- Takeda (TAK) Reports Positive Phase 3 Data for Zasocitinib in Pl
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Takeda?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili